- Home
- THRD vs BIGC Comparison
THRD vs BIGC Comparison
Compare THRD & BIGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- BIGC
- Stock Information
- Founded
- THRD 2019
- BIGC 2009
- Country
- THRD United States
- BIGC United States
- Employees
- THRD N/A
- BIGC N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- BIGC Computer Software: Prepackaged Software
- Sector
- THRD Health Care
- BIGC Technology
- Exchange
- THRD Nasdaq
- BIGC Nasdaq
- Market Cap
- THRD 513.2M
- BIGC 432.3M
- IPO Year
- THRD 2022
- BIGC 2020
- Fundamental
- Price
- THRD $12.47
- BIGC $6.83
- Analyst Decision
- THRD Strong Buy
- BIGC Hold
- Analyst Count
- THRD 3
- BIGC 9
- Target Price
- THRD $20.33
- BIGC $8.61
- AVG Volume (30 Days)
- THRD 233.9K
- BIGC 974.8K
- Earning Date
- THRD 11-07-2024
- BIGC 11-07-2024
- Dividend Yield
- THRD N/A
- BIGC N/A
- EPS Growth
- THRD N/A
- BIGC N/A
- EPS
- THRD N/A
- BIGC N/A
- Revenue
- THRD N/A
- BIGC $330,048,000.00
- Revenue This Year
- THRD N/A
- BIGC $9.74
- Revenue Next Year
- THRD N/A
- BIGC $5.39
- P/E Ratio
- THRD N/A
- BIGC N/A
- Revenue Growth
- THRD N/A
- BIGC 10.87
- 52 Week Low
- THRD $7.08
- BIGC $5.13
- 52 Week High
- THRD $16.94
- BIGC $10.19
- Technical
- Relative Strength Index (RSI)
- THRD 46.72
- BIGC 66.96
- Support Level
- THRD $10.10
- BIGC $5.89
- Resistance Level
- THRD $12.49
- BIGC $7.12
- Average True Range (ATR)
- THRD 1.23
- BIGC 0.38
- MACD
- THRD -0.25
- BIGC 0.10
- Stochastic Oscillator
- THRD 43.89
- BIGC 85.64
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About BIGC BigCommerce Holdings Inc. Series 1
BigCommerce Holdings Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of revenue is generated from Americas-U.S.